Skip to content

Plasma or Serum Protein Profile for Fetus (24-Hour Collection)

Published: August 9, 2026Updated: August 16, 2026

This test measures various proteins in your baby’s blood, collected over a 24-hour period, to assess fetal health and development.

Quick summary

["Understanding protein levels in fetal blood can help monitor growth and potential health risks."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
61190-5
Short code
PT PPP Fetus
Synonyms
PT PPP Fetus
Category
chemistry
Sample
plasma
Container
Lavender-top (EDTA) or Green-top (Heparin)
Units
N/A
Ref low
0.8
Ref high
1.2
Critical range
— – 5 N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
coag-tissue-factor-induced
CPT
85610
SNOMED
396252006
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Is Done

Doctors may order this test if there are concerns about fetal growth restrictions, genetic conditions, or other health issues that could affect protein metabolism in the fetus. It helps evaluate how well the baby’s body is producing and processing proteins, which are essential for growth and development.

What to Expect Before the Test

You’ll need to collect a small amount of blood from your baby’s umbilical cord or placenta over 24 hours. This is typically done in a hospital setting with medical supervision. Your healthcare provider will guide you through the process and ensure it’s safe and accurate.

What the Results Mean

The results provide a detailed profile of protein levels, including markers like albumin, transferrin, and others. Abnormal levels may indicate issues such as protein malnutrition, genetic disorders, or other metabolic problems that could impact fetal health.

Common Conditions Monitored

This test is often used to monitor conditions like intrauterine growth restriction (IUGR), certain genetic syndromes, or metabolic disorders that affect protein synthesis or breakdown in the fetus.

Reference range

INR: 0.8-1.2 (warfarin: 2.0-3.0)N/A

Specimen: plasma

Inform your healthcare provider if you are taking blood thinners. No special preparation required.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance

Short name

Fetal Protein Profile (24h)

Frequently asked questions

How often will I need to return for this test?
The frequency depends on your healthcare provider’s recommendations. Some patients may need this test periodically if they have ongoing concerns about fetal health or specific medical conditions.
What are the risks or side effects of this test?
The procedure involves a small blood draw, which may cause mild discomfort or bruising. There are no major risks associated with this test, but always discuss any concerns with your healthcare provider.
Can I eat or drink before the test?
You may need to follow specific instructions regarding diet or hydration, as some tests require fasting or particular timing. Your healthcare team will provide guidance tailored to your situation.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy